RENNOVA HEALTH ANNOUNCES APPOINTMENT OF NEW CHIEF EXECUTIVE OFFICER AT JAMESTOWN MEDICAL CENTER

    NEXT STORY
    Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA)
    PREV STORY
    Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeiGene Reports Third Quarter 2016 Financial Results

    WALTHAM, Mass., Nov. 10, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Gradalis Announces Medical Leadership Team Promotion

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the directed share issue without payment to the Company itself

    author_avatar
    NASDAQ Market News